Xeris Biopharma Holdings, Inc.

By person

18 insiders · 61 transactions

33.1×

John Shannon holds 33.1 times base salary in stock. $24.64M of shares against $742.33K in salary for 2025.

Salary from the company's own proxy. The shares are what John Shannon last reported holding, valued at $8.50, the price Common Stock was last bought or sold at on the open market here, on 1 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

JOHNSON JOHN

Director

—

$1.85M (3)

−$1.85M

707,276

0.3879%

$6.01M

—

Hecht Beth

See Remarks

—

$1.52M (13) scheduled

−$1.52M

1,127,796

0.6186%

$9.59M

+2,919%

McCulloch Kevin

See Remarks

$109.48K (1)

$1.09M (4) scheduled

−$980.58K

1,664,208

0.9128%

$14.15M

+11.6%

Edick Paul R

See Remarks

$654.60K (5)

—

+$654.60K

3,821,494

2.10%

$32.48M

—

HALKUFF DAWN

Director

$9.95K (1)

$431.11K (2)

−$421.16K

124,603

0.0683%

$1.06M

—

Pieper Steven

See Remarks

$104.52K (2)

$468.18K (4) scheduled

−$363.66K

1,356,053

0.7438%

$11.53M

+7,469%

SHERMAN JEFFREY W

Director

$10.10K (1)

$334.52K (1) scheduled

−$324.42K

224,588

0.1232%

$1.91M

—

BORMANN-KENNEDY BARBARA-JEAN ANNE

Director

—

$203.92K (2) scheduled

−$203.92K

150,693

0.0827%

$1.28M

—

PERSKY MARLA

Director

$10.06K (1)

$211.04K (2) scheduled

−$200.99K

157,063

0.0861%

$1.34M

—

Shannon John Patrick Jr

See Remarks

$259.90K (3)

$349.66K (2) scheduled

−$89.76K

2,898,933

1.59%

$24.64M

+8,892%

Brady James Aloysius

Director

—

$60.04K (1) scheduled

−$60.04K

113,359

0.0622%

$963.55K

—

Schmid John P.

Director

$50.13K (5)

—

+$50.13K

138,359

0.0759%

$1.18M

—

PRESTRELSKI STEVEN

Chief Scientific Officer

—

$27.16K (1) scheduled

−$27.16K

719,780

0.3948%

$6.12M

—

Nguyen Anh Tu

See Remarks

—

395,023

0.2167%

$3.36M

+30.4%

JOHNSON KENNETH ERLAND

See Remarks

—

320,446

0.1758%

$2.72M

+3,278%

Kong Garheng

Director

—

238,337

0.1307%

$2.03M

—

Fairley Ricki Louise

Director

—

135,000

0.0740%

$1.15M

—

KREHER NERISSA

Director

—

33,582

0.0184%

$285.45K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Shannon John Patrick Jr

5 Jan 2026

See Remarks

Sold after exercise

24,907

$7.08

$176.26K

Shannon John Patrick Jr

13 Nov 2025

See Remarks

Sold after exercise

23,242

$7.46

$173.40K

SHERMAN JEFFREY W

28 Aug 2025

Director

Sold after exercise

42,232

$7.92

$334.52K

PRESTRELSKI STEVEN

22 Feb 2022

Chief Scientific Officer

Sold after exercise

11,228

$2.42

$27.16K

Show all 61 transactions →

Xeris Biopharma Holdings, Inc.

By person

Individual transactions

What was left out